Published in J Pathol Clin Res on September 12, 2015
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature (1995) 5.48
Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort. J Clin Oncol (2014) 4.90
Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest (2005) 4.84
Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol (2001) 4.18
Roles of HMGA proteins in cancer. Nat Rev Cancer (2007) 3.98
Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer (2005) 3.75
Molecular biology of HMGA proteins: hubs of nuclear function. Gene (2001) 3.69
Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol (2005) 2.69
Testicular germ-cell cancer. Lancet (2006) 2.64
Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest (2005) 2.60
The HMGA proteins: a myriad of functions (Review). Int J Oncol (2008) 2.42
HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta (2001) 2.30
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol (2007) 2.21
High level expression of the HMGI (Y) gene during embryonic development. Oncogene (1996) 2.13
International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev (2010) 2.07
HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol (1996) 1.76
Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol (1997) 1.70
Testicular cancer variations in time and space in Europe. Eur Urol (2006) 1.67
International patterns and trends in testis cancer incidence. Int J Cancer (2005) 1.60
The continued value of central histopathological review of testicular tumours. Histopathology (2005) 1.46
HMGA and cancer. Biochim Biophys Acta (2010) 1.45
Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol (2003) 1.44
HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB. Mol Cancer Res (2007) 1.42
Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res (2006) 1.41
SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol (2009) 1.39
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol (2007) 1.37
The value of central histopathological review of testicular tumours before treatment. BJU Int (1999) 1.35
The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer (1998) 1.33
Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol (2006) 1.29
Pathology of germ cell tumors of the testis. Cancer Control (2004) 1.28
Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis. Int J Androl (2011) 1.26
Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance. J Pathol (2010) 1.24
Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers. Clin Cancer Res (2011) 1.23
Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res (2005) 1.23
Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. J Pathol (2009) 1.19
Establishment of human trophoblast progenitor cell lines from the chorion. Stem Cells (2011) 1.15
Glypican 3: a novel marker in testicular germ cell tumors. Am J Surg Pathol (2006) 1.14
Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Ann Oncol (2005) 1.11
HMGA1 and HMGA2 protein expression in mouse spermatogenesis. Oncogene (2002) 1.11
A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells. Oncogene (2005) 1.10
Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis. Ann N Y Acad Sci (2007) 1.07
RNA-binding protein LIN28 is a marker for testicular germ cell tumors. Hum Pathol (2011) 1.07
Oncofetal protein glypican-3 in testicular germ-cell tumor. Virchows Arch (2006) 0.96
Phosphorylation of high-mobility group protein A2 by Nek2 kinase during the first meiotic division in mouse spermatocytes. Mol Biol Cell (2003) 0.94
Recent developments in testicular germ cell tumor research. Birth Defects Res C Embryo Today (2009) 0.93
TGF-β1, EGF and FGF4 synergistically induce differentiation of the seminoma cell line TCam-2 into a cell type resembling mixed non-seminoma. Int J Androl (2011) 0.92
LIN28 Expression in malignant germ cell tumors downregulates let-7 and increases oncogene levels. Cancer Res (2013) 0.92
Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases. Mod Pathol (2010) 0.90
The impact of histological review on clinical management of testicular cancer. Br J Urol (1993) 0.90
Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition. Cell Prolif (2014) 0.88
Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours. J Pathol (2008) 0.88
Germ cell lineage differentiation in non-seminomatous germ cell tumours. J Pathol (2006) 0.87
Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas. Mod Pathol (2009) 0.87
HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases. Virchows Arch (2012) 0.86
Testicular cancer: the challenge for cancer control. Lancet Oncol (2004) 0.84
Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: an overview. J Cell Physiol (2013) 0.83
An up-date on newly discovered immunohistochemical biomarkers for the diagnosis of human testicular germ cell tumors. Histol Histopathol (2014) 0.82
A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sac. Histopathology (2014) 0.79
Seminoma with tubular, microcystic, and related patterns: a study of 28 cases of unusual morphologic variants that often cause confusion with yolk sac tumor. Am J Surg Pathol (2005) 0.78
New prognostic markers and potential therapeutic targets in human testicular germ cell tumors. Curr Med Chem (2011) 0.77
The expression of HMGA2 varies strongly among colon carcinomas. Anticancer Res (2012) 0.77
Expression of human chorionic gonadotropin in testicular germ cell tumors. Urol Oncol (2014) 0.76
Update on testis tumours. Pathology (2012) 0.76
Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registries. Cancer (1998) 0.76